Aarti Industries Ltd (AARTIIND)

Chemicals · Chemicals · NSE · Updated 13 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹492.15 ↑ 26.31% (1Y)

🎯 Key Takeaways

  • Aarti Industries is transitioning from a promoter-led to professionally managed specialty chemicals company, with a strategic pivot toward high-margin segments and ESG leadership. The appointment of Suyog K.
  • Revenue grew 8.3% QoQ to ₹2,387 in Q1FY27.
  • ⚠️ Raw material price volatility remains a concern, with no hedging strategy disclosed in filings.
Market Cap
₹17,852
P/E Ratio
33.6
P/B Ratio
3.18
ROE
9.5%
ROCE
9.2%
Debt/Equity
0.68
Div Yield
0.20%
Promoter
41.8%

📖 The Story

Aarti Industries is transitioning from a promoter-led to professionally managed specialty chemicals company, with a strategic pivot toward high-margin segments and ESG leadership. The appointment of Suyog K. Kotecha as MD marks a governance shift, while long-term contracts and capex plans signal intent to scale specialty materials and sustainable operations. Despite stable margins, near-term growth is expected from Zone IV platform rollout and agrochemical deal execution, targeting ROCE above 20% for new investments.

📰 What's Happening

The company filed its 2025-26 Integrated Annual Report on August 27, 2026, announcing Suyog K. Kotecha’s appointment as Managing Director effective October 1, 2026, replacing promoter directors in executive roles. The 43rd AGM is scheduled for September 21, 2026, where director remuneration and re-appointments will be voted on. A proposed 20% dividend (Re.1 per share) is tied to shareholder approval, with record date set for September 14, 2026, and payment by October 9, 2026. Capex of ₹750-800 Crs is planned for FY27, supported by USD 150 million in long-term agrochemical contracts. ESG milestones include EcoVadis Platinum, CDP A-List, and SBTi-validated targets (54.6% Scope 1 & 2 emissions reduction by FY33), with 95% waste recycling and 81% Zero Waste to Landfill certification. Material risks cited include raw material volatility, US tariffs, and regulatory changes.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricSep 2025Dec 2025Mar 2026Jun 2026
Revenue2,1002,3182,2052,387
Operating Profit171200222258
OPM %8.1%8.6%10.1%10.8%
Net Profit106133137155
EPS₹2.91₹3.67₹3.79₹4.27

Quarterly revenue has shown sequential growth from ₹2,100 Crs (Sep 2025) to ₹2,387 Crs (Jun 2026), with OPM expanding from 8.1% to 10.8% over the same period, indicating margin improvement. PAT rose from ₹106 Crs to ₹155 Crs, and EPS increased from ₹2.91 to ₹4.27, reflecting operational efficiency gains. However, net debt remains elevated at ₹4,966 Crs as of Mar 2026, up from ₹3,790 Crs a year ago, driven by capital investments. Despite this, EBITDA margin expansion and improving profitability suggest that operational performance is aligning with strategic investments, though margin pressure persists due to external market dynamics.

🔮 Management Outlook & What's Next

Management expects revenue growth from the Zone IV platform to materialize in H2 of FY26-27, driven by specialty chemicals and advanced materials. Capex of ₹750-800 Crs in FY27 is targeted at enhancing capacity and sustainability infrastructure, with a focus on achieving >20% pre-tax ROCE on new investments. Net debt-to-EBITDA is projected to decline below 2.5x within 12-24 months, supported by improved cash flows and deleveraging. Long-term contracts, including the USD 150 million agrochemical deal, are expected to provide revenue visibility. ESG targets are integrated into capital allocation, with climate goals tied to operational planning.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2025Mar 2025Mar 2026Mar 2026
Equity Capital181181181181
Reserves5,2625,4245,5315,774
Borrowings3,8833,7903,9734,966
Total Liabilities10,53811,11411,70213,299
Fixed Assets5,6886,5576,3516,302
Investments364881132
Total Assets10,53811,11411,70213,299

Total assets have grown from ₹11,114 Crs (Mar 2025) to ₹13,299 Crs (Mar 2026), reflecting increased investments in plant and machinery, likely tied to FY27 capex plans. Borrowings rose to ₹4,966 Crs from ₹3,790 Crs over the same period, indicating higher leverage, but equity remains stable at ₹181 Crs with reserves growing to ₹5,774 Crs. Despite rising debt, the company maintains a manageable D/E of 0.68, and net debt-to-EBITDA is expected to improve to below 2.5x within two years, suggesting a deliberate but controlled capitalization strategy focused on long-term growth rather than aggressive expansion.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2025
Operating+1,242
Investing-1,398
Financing-73
Net Cash Flow-229

👥 Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters42.2%42.1%42.1%41.8%
FII6.4%6.7%7.4%7.0%
DII18.2%18.2%20.1%21.1%
Public28.5%28.2%25.8%25.5%
# Shareholders4,28,9314,18,4923,84,2103,70,868

Promoter holding has slightly declined from 42.18% (Q2FY26) to 41.82% (Q1FY27), while FII ownership increased from 6.4% to 6.99%, and DII from 18.21% to 21.11%, indicating growing institutional confidence. The number of shareholders has decreased slightly from 4,28,931 (Q2FY26) to 3,70,868 (Q1FY27), suggesting consolidation but broader retail participation. No pledging or significant exits by promoters are evident, and the rise in DII and FII holdings aligns with the professionalization narrative. The upcoming AGM and dividend proposal may further attract institutional interest.

⚖️ Peer Comparison — Chemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
PIDILITIND 1.60 L Cr 60.2 33.4% 24.7% 0.01
SRF 73,602 34.0 15.6% 15.4% 0.36
LINDEINDIA 53,075 97.2 17.5% 12.8% 0.00
FLUOROCHEM 52,418 85.7 9.6% 7.7% 0.34
NAVINFLUOR 43,808 55.4 22.2% 19.9% 0.31
GODREJIND 37,958 32.3 9.2% 19.8% 4.57
HSCL 33,544 41.7 20.7% 17.1% 0.16
AETHER 22,202 94.1 13.8% 10.6% 0.08
DEEPAKNTR 21,647 27.6 15.3% 13.4% 0.26
CASTROLIND 18,591 17.5 76.2% 55.9% 0.00

⚠️ Risk Factors

1. Raw material price volatility remains a concern, with no hedging strategy disclosed in filings. 2. US tariffs on chemical exports pose a material headwind, given global exposure. 3. Regulatory changes in environmental or import policies could impact margins and compliance costs. 4. Execution risk around Zone IV platform and capex utilization, as scalability of new investments is unproven. 5. Despite ESG leadership, transition costs and sustainability-linked financing may increase capital intensity in the near term.

📋 Recent Filings

🧠 Analyst's Read

Aarti Industries is undergoing a structural shift toward specialty chemicals and professional governance, supported by strategic capex, long-term contracts, and ESG commitments. While near-term margin pressures and elevated leverage persist, the trajectory toward higher ROCE and sustainable growth is clear. Investors should monitor Zone IV platform ramp-up, debt reduction pace, and AGM approval of the dividend and MD appointment as near-term catalysts.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-13.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AARTIIND files new disclosures

Track AARTIIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AARTIIND — Free

Free account · 2 AI queries/day